Joseph Krantzler
Cardiovascular Disease · Pottstown, PANPI 1023098894
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Johnson & Johnson at 30.2% of the total. Reporting peaked in 2019 at $2,072 and has fallen 76.4% since, to $489 in 2022.
Across 217 payments — averaging $22.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Novartis$581
- Amgen$545
- AstraZeneca$376
- Pfizer$358
- Sanofi-aventis U.S. LLC$234
- plus $1K from 19 others
Across 3 payments — averaging $1433.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$4K
What the payments were for
- Food & beverage$4,78899%
- Education$611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 42 | $1,464 |
| Novartis | 24 | $581 |
| Amgen | 29 | $545 |
| AstraZeneca | 16 | $376 |
| Pfizer | 26 | $358 |
| Sanofi-aventis U.S. LLC | 16 | $234 |
| Boehringer Ingelheim | 11 | $168 |
| E.r. Squibb & Sons, L.L.C. | 11 | $151 |
| Lundbeck LLC | 3 | $146 |
| Abbott | 2 | $139 |
| Preventice Services, LLC | 5 | $117 |
| Biotronik Inc. | 3 | $104 |
| Amarin Pharma, Inc. | 7 | $99 |
| Microport CRM USA Inc | 2 | $84 |
| Kowa Pharmaceuticals America, Inc. | 5 | $65 |
| Regeneron Healthcare Solutions, Inc. | 3 | $36 |
| Atricure, Inc. | 2 | $29 |
| Merck | 2 | $26 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $24 |
| Shire North American Group Inc | 1 | $24 |
| Bayer | 1 | $19 |
| Braemar Manufacturing, LLC | 1 | $17 |
| Boston Scientific | 1 | $14 |
| Lantheus Medical Imaging, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,849 in reported general payments places this provider in the 70th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Other cardiovascular disease in Pottstown
- Hemal GadaWormleysburg$1.8M
- Benjamin KalsmithPgh$1.7M
- Peter KoweyWynnewood$1.5M
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Rhian DaviesYork$853K
- Sarang MangalmurtiBryn Mawr$728K
- Sabahat BokhariAllentown$578K
- George GabrielPittsburgh$563K
- Rajesh DaveCamp Hill$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.